2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of STT3B mRNA CTD PMID:21570461 4,4'-diaminodiphenylmethane decreases expression ISO RGD:1311563 6480464 4, 4'-diaminodiphenylmethane results in decreased expression of STT3B mRNA CTD PMID:30723492 aflatoxin B1 decreases methylation ISO RGD:1606939 6480464 Aflatoxin B1 results in decreased methylation of STT3B intron CTD PMID:30157460 Aroclor 1254 decreases expression EXP 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of STT3B mRNA CTD PMID:23650126 atrazine increases expression ISO RGD:1606939 6480464 Atrazine results in increased expression of STT3B mRNA CTD PMID:22378314 benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of STT3B mRNA CTD PMID:21569818 Benzo[k]fluoranthene increases expression EXP 6480464 benzo(k)fluoranthene results in increased expression of STT3B mRNA CTD PMID:26377693 bisphenol A decreases methylation EXP 6480464 bisphenol A results in decreased methylation of STT3B promoter CTD PMID:27312807 buta-1,3-diene increases expression EXP 6480464 1, 3-butadiene results in increased expression of STT3B mRNA CTD PMID:29038090 carbon nanotube affects expression EXP 6480464 Nanotubes, Carbon affects the expression of STT3B mRNA, Nanotubes, Carbon analog affects the expression of STT3B mRNA CTD PMID:25554681 carbon nanotube increases expression EXP 6480464 Nanotubes, Carbon analog results in increased expression of STT3B mRNA, Nanotubes, Carbon results in increased expression of STT3B mRNA CTD PMID:25620056 chloroprene increases expression EXP 6480464 Chloroprene results in increased expression of STT3B mRNA CTD PMID:23125180 choline multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of STT3B gene CTD PMID:20938992 dorsomorphin multiple interactions ISO RGD:1606939 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 ethanol affects splicing EXP 6480464 Ethanol affects the splicing of STT3B mRNA CTD PMID:30319688 ethanol affects expression EXP 6480464 Ethanol affects the expression of STT3B mRNA CTD PMID:30319688 flutamide decreases expression ISO RGD:1311563 6480464 Flutamide results in decreased expression of STT3B mRNA CTD PMID:24136188 folic acid multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of STT3B gene CTD PMID:20938992 L-methionine multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of STT3B gene CTD PMID:20938992 mercury dibromide decreases expression ISO RGD:1606939 6480464 mercuric bromide results in decreased expression of STT3B mRNA CTD PMID:26272509 methylmercury chloride decreases expression ISO RGD:1606939 6480464 methylmercuric chloride results in decreased expression of STT3B mRNA CTD PMID:28001369 p-chloromercuribenzoic acid decreases expression ISO RGD:1606939 6480464 p-Chloromercuribenzoic Acid results in decreased expression of STT3B mRNA CTD PMID:26272509 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of STT3B mRNA CTD PMID:17562736 perfluorooctanoic acid decreases expression ISO RGD:1606939 6480464 perfluorooctanoic acid results in decreased expression of STT3B protein CTD PMID:26879310 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of STT3B mRNA CTD PMID:23811191 propiconazole increases expression EXP 6480464 propiconazole results in increased expression of STT3B mRNA CTD PMID:21278054 resveratrol increases expression EXP 6480464 resveratrol results in increased expression of STT3B protein CTD PMID:25505154 SB 431542 multiple interactions ISO RGD:1606939 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 sodium arsenite decreases expression ISO RGD:1606939 6480464 sodium arsenite results in decreased expression of STT3B mRNA CTD PMID:28595984 Soman increases expression ISO RGD:1311563 6480464 Soman results in increased expression of STT3B mRNA CTD PMID:19281266 titanium dioxide increases expression EXP 6480464 titanium dioxide results in increased expression of STT3B mRNA CTD PMID:27760801 titanium dioxide affects expression EXP 6480464 titanium dioxide affects the expression of STT3B mRNA CTD PMID:17656681 toluene increases expression ISO RGD:1311563 6480464 Toluene results in increased expression of STT3B mRNA CTD PMID:22967744 trichostatin A increases expression ISO RGD:1606939 6480464 trichostatin A results in increased expression of STT3B mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:1606939 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of STT3B mRNA CTD PMID:27188386 tunicamycin increases expression ISO RGD:1606939 6480464 Tunicamycin results in increased expression of STT3B mRNA CTD PMID:22378314 , PMID:29453283 valproic acid decreases methylation ISO RGD:1606939 6480464 Valproic Acid results in decreased methylation of STT3B gene CTD PMID:29154799 valproic acid affects expression ISO RGD:1606939 6480464 Valproic Acid affects the expression of STT3B mRNA CTD PMID:23179753 valproic acid increases expression ISO RGD:1606939 6480464 Valproic Acid results in increased expression of STT3B mRNA CTD PMID:26272509 valproic acid multiple interactions ISO RGD:1606939 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of STT3B mRNA CTD PMID:27188386 valproic acid decreases expression ISO RGD:1606939 6480464 Valproic Acid results in decreased expression of STT3B mRNA CTD PMID:27188386
Biological Process co-translational protein modification ISO UniProtKB:Q8TCJ2 2290270 MGI GO_REF:0000096, MGI:MGI:4834177 glycoprotein catabolic process ISO UniProtKB:Q8TCJ2 2290270 MGI GO_REF:0000096, MGI:MGI:4834177 post-translational protein modification ISO UniProtKB:Q8TCJ2 2290270 MGI GO_REF:0000096, MGI:MGI:4834177 post-translational protein modification IBA PANTHER:PTN000356206 , UniProtKB:Q8TCJ2 2290270 (PMID:21873635) GO_Central PMID:21873635 post-translational protein modification IBA PANTHER:PTN000356208 , UniProtKB:Q8TCJ2 2290270 (PMID:21873635) GO_Central PMID:21873635 protein glycosylation IEA InterPro:IPR003674 2290270 UniProtKB GO_REF:0000002, MGI:MGI:2152098 protein N-linked glycosylation via asparagine ISO UniProtKB:Q8TCJ2 2290270 MGI GO_REF:0000096, MGI:MGI:4834177 protein N-linked glycosylation via asparagine IBA PANTHER:PTN000356206 more ... 2290270 (PMID:21873635) GO_Central PMID:21873635 protein N-linked glycosylation via asparagine IBA PANTHER:PTN000356208 more ... 2290270 (PMID:21873635) GO_Central PMID:21873635 response to unfolded protein ISO UniProtKB:Q8TCJ2 2290270 MGI GO_REF:0000096, MGI:MGI:4834177 ubiquitin-dependent ERAD pathway ISO UniProtKB:Q8TCJ2 2290270 MGI GO_REF:0000096, MGI:MGI:4834177 Cellular Component endoplasmic reticulum ISO UniProtKB:Q8TCJ2 2290270 MGI GO_REF:0000096, MGI:MGI:4834177 integral component of membrane IEA UniProtKB-KW:KW-0812 2290270 UniProtKB GO_REF:0000004, MGI:MGI:1354194 membrane IEA UniProtKB-KW:KW-0472 2290270 UniProtKB GO_REF:0000004, MGI:MGI:1354194 membrane IEA InterPro:IPR003674 2290270 UniProtKB GO_REF:0000002, MGI:MGI:2152098 oligosaccharyltransferase complex IBA PANTHER:PTN000356206 more ... 2290270 (PMID:21873635) GO_Central PMID:21873635 protein-containing complex ISO UniProtKB:Q8TCJ2 2290270 (MGI:MGI:5902878, PMID:28246125) MGI MGI:MGI:5902878 , PMID:28246125 Molecular Function dolichyl-diphosphooligosaccharide-protein glycotransferase activity ISO UniProtKB:Q8TCJ2 2290270 MGI GO_REF:0000096, MGI:MGI:4834177 dolichyl-diphosphooligosaccharide-protein glycotransferase activity IBA PANTHER:PTN000356206 more ... 2290270 (PMID:21873635) GO_Central PMID:21873635 dolichyl-diphosphooligosaccharide-protein glycotransferase activity IBA PANTHER:PTN000356208 more ... 2290270 (PMID:21873635) GO_Central PMID:21873635 metal ion binding IEA UniProtKB-KW:KW-0479 2290270 UniProtKB GO_REF:0000004, MGI:MGI:1354194 oligosaccharyl transferase activity IEA InterPro:IPR003674 2290270 UniProtKB GO_REF:0000002, MGI:MGI:2152098 transferase activity IEA UniProtKB-KW:KW-0808 2290270 UniProtKB GO_REF:0000004, MGI:MGI:1354194 transferase activity, transferring glycosyl groups IEA UniProtKB-KW:KW-0328 2290270 UniProtKB GO_REF:0000004, MGI:MGI:1354194
Gene-Chemical Interaction Annotations
